Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen

Sandra Holt,Jonas Nilsson,Romelda Omeir,Gunnar Tiger,Christopher J Fowler
DOI: https://doi.org/10.1038/sj.bjp.0704113
IF: 7.3
2001-06-01
British Journal of Pharmacology
Abstract:The pharmacological properties of fatty acid amidohydrolase (FAAH) at different assay pH values were investigated using [3H]‐anandamide ([3H]‐AEA) as substrate in rat brain homogenates and in COS‐7 cells transfected with wild type and mutant FAAH. Rat brain hydrolysis of [3H]‐AEA showed pH dependency with an optimum around pH 8‐9. Between pH 6.3 and 8.2, the difference in activity was due to differences in the Vmax, rather than the KM values. For inhibition of rat brain [3H]‐AEA metabolism by a series of known FAAH inhibitors, the potencies of the enantiomers of ibuprofen and phenylmethylsulphonyl fluoride (PMSF) were higher at pH 5.28 than at pH 8.37, whereas the reverse was true for oleyl trifluoromethylketone (OTMK) and arachidonoylserotonin. At both pH values, (−)ibuprofen was a mixed‐type inhibitor of FAAH. The Ki(slope) and Ki(intercept) values for (−)ibuprofen at pH 5.28 were 11 and 143 μM, respectively. At pH 8.37, the corresponding values were 185 and 3950 μM, respectively. The pH dependency for the inhibition by OTMK and (−)ibuprofen was also seen in COS‐7 cells transiently transfected with either wild type, S152A or C249A FAAH. No differences in potencies between the wild type and mutant enzymes were seen. It is concluded that the pharmacological properties of FAAH are highly pH‐dependent. The higher potency of ibuprofen at lower pH values raises the possibility that in certain types of inflamed tissue, the concentration of this compound following oral administration may be sufficient to inhibit FAAH. British Journal of Pharmacology (2001) 133, 513–520; doi:10.1038/sj.bjp.0704113
pharmacology & pharmacy
What problem does this paper attempt to address?